Keywords: akzo, nobel, 2nd-qtr, sales, hit, 57b, euros
Akzo Nobel's 2nd-qtr sales hit 3.57B euros
Article | 31 July 2006
Dutch pharmaceutical and chemicals firm Akzo Nobel said that its second quarter 2006 operating income was 365.0 million euros ($462.6 million), falling short ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
